Skip to main content
Malcolm Foster III, MD, Cardiology, Farragut, TN

Malcolm Foster III MD

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Cardiothoracic Imaging, Preventive Cardiology


Director Cardiovascular Research

Join to View Full Profile
  • 10800 Parkside DrSte 331Farragut, TN 37934

  • Phone+1 865-392-3400

  • Fax+1 865-392-3449

Dr. Foster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Michigan State University
    Michigan State UniversityFellowship, Interventional Cardiology, 1997 - 1997
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 1994 - 1997
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 1991 - 1994
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1991

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2001 - 2025
  • MD State Medical License
    MD State Medical License 1993 - 1994
  • Interventional Cardiology
    American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Tennova Turkey Creek Celebrates Milestone Cardiovascular Research
    Tennova Turkey Creek Celebrates Milestone Cardiovascular ResearchSeptember 7th, 2021
  • Endovascular Engineering Treats First Patient in Trial of Hēlo System
    Endovascular Engineering Treats First Patient in Trial of Hēlo SystemFebruary 22nd, 2024
  • Endovascular Engineering Begins ENGULF Pivotal Trial of Helo PE Thrombectomy System
    Endovascular Engineering Begins ENGULF Pivotal Trial of Helo PE Thrombectomy SystemFebruary 23rd, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: